<DOC>
	<DOCNO>NCT02226588</DOCNO>
	<brief_summary>The objective study compare two community-level strategy : either selective , early administration 800 mcg sublingual misoprostol woman secondary prevention postpartum hemorrhage ( PPH ) universal use 600 mcg oral misoprostol time delivery prophylaxis PPH . The significance cluster randomize non-inferiority trial potential inform service delivery program clinical outcome , program feasibility , cost , acceptability two different community model PPH care use misoprostol.1 . The study hypothesize service delivery model administers misoprostol secondary prevention non-inferior model administers misoprostol universal prophylaxis .</brief_summary>
	<brief_title>Comparison Primary Secondary Prevention Postpartum Hemorrhage Community Level Egypt</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Postpartum Hemorrhage</mesh_term>
	<mesh_term>Misoprostol</mesh_term>
	<criteria>Willing able give inform consent Vaginal delivery Agrees participate followup interview Agrees pre posthemoglobin take Delivery woman 's home primary health unit ( PHU ) Too advance active labor provide consent Known allergy misoprostol and/or prostaglandin Pregnancy complication , hypertension , suspect multiple pregnancy , previous caesarean section , suspect still birth , antepartum hemorrhage , previous complication third trimester</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>